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Fibrillary glomerulonephritis: an entity with unusual immunofluores-
cence features. We describe seven patients with renal biopsy findings of
mild glomerular abnormalities on light microscopy but with prominent
accumulation of randomly—arranged fibrillar material in the mesangium
and capillary walls on electron microscopy. This material differed from
amyloid in that fibrils were thicker (diameter range 10 to 19.5 nm) and
did not stain with Congo Red. In six of seven cases fluorescence
microscopy showed prominent staining for IgG and kappa light chain in
mesangium and glomerular capillary walls; in three cases weak lambda
chain staining was also present. Stains for IgA, 1gM, and lambda chain
were otherwise negative. One biopsy showed equal staining for kappa
and lambda light chains, but not for heavy chain components. Clinical
findings were heterogeneous. Patients presented with features of
nephritis and/or nephrotic syndrome. No patient had an associated
lymphoplasmacytic disorder, paraproteinemia, or other evidence of
systemic disease. On follow—up ranging from five months to 12 years,
all patients are still alive; six progressed to end—stage renal disease
requiring dialysis. One patient developed recurrent disease in a renal
allograft five years after transplantation. Non-amyloidotic fibrillary
glomerulonephritis is an ultrastructurally distinct entity of undeter-
mined etiology. The apparent association with monoclonal lgG and
kappa light chain deposition observed in this series deserves further
study.
Until recently, renal disease associated with parenchymal
deposits of randomly—arranged fibrillar material has been inter-
preted almost invariably as amyloidosis. With increasingly
widespread use of antisera to light chains in the evaluation of
renal biopsies, it has become apparent that fibrillary deposits of
somewhat heterogeneous ultrastructural appearances can be
found in exceptional cases of glomerulopathies associated with
immunoglobulin or light chain deposition, usually containing a
kappa chain subclass [1—5]. Renal fibrillar deposits have also
been recognized in cryoglobulinemia, although these often have
a characteristic organized pattern [6]. Most recently, there have
been reports of glomerulopathies associated with deposits of
fibrillar, amyloid—like material but which differs from classic
amyloid in its light microscopic tinctorial qualities and its larger
fibril size [7—121. Many of these cases, however, were not
specifically studied for patterns of light chain deposition.
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We report here a series of seven patients with a glomerular
disease that on pathologic examination has a characteristic
ultrastructural appearance of amyloid—like deposits but which is
distinguished from amyloid by several pathologic features.
Although our cases have some clinical and pathological features
in common with the patients reported by Duffy et al [10] and
Sturgill, Bolton and Griffith [12], a striking finding is an appar-
ent association between the presence of fibrillar deposits and
immunofluorescence staining of glomeruli for kappa light chains
and apparently monoclonal-IgG kappa immunoglobulin. While
the reasons for this association remain undetermined, the
patients in our series had no evidence of an extra—renal
lymphoproliferative disorder at the time of renal biopsy. Simi-
larly, these patients are without evidence of any of the other
diseases known to predispose to the development of amyloido-
sis. For these reasons, we do not regard these patients as having
"atypical" amyloidosis, but rather as exhibiting a distinct
disease process whose full pathological, biochemical, and clin-
ical expression will be better understood as more such patients
are identified and studied. Although the patients in the present
series showed considerable heterogeneity in their clinicaJ symp-
tomatology at the time of first presentation, their subsequent
clinical course is noteworthy for a rapid progression to
end—stage renal disease in most cases.
Methods
Cases were identified by review of the entire renal biopsy
experience at two institutions, the University of California, San
Francisco, and the Brigham and Women's Hospital, over a five
year period. Two patients (cases I and 2) have been previously
reported prior to assembling the present series [5, 13].
Renal biopsy tissue was prepared for light microscopy ac-
cording to conventional techniques. A portion of the biopsy
tissue was snap frozen, sectioned, and stained with fluoresce-
in—conjugated goat antisera directed against human IgG, 1gM,
IgA, C3, fibrinogen, albumin, lambda, and kappa chains ob-
tained from Meloy Laboratories, Inc. (Springfield, Virginia,
USA) or Cappel Laboratories (West Chester, Pennsylvania,
USA). Tests for specificity of activity included immuno-
electrophoresis of the goat antisera against a panel of purified
human proteins. Sensitivity of the antisera and reagents was
demonstrated by parallel immunofluorescence examination of
known positive and negative kidney biopsies from patients with
immune complex—mediated diseases and renal cortex from
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Table 1. Clinical profile
Patients
Case Age (yr)/race/sex Clinical presentation Associated medical history Follow—up observations Time elapsed after biopsy
I 46/B/M Accelerated hypertension
Acute renal failure
None Rapid progression to ESRD
requiring dialysis
1.5 years
2 19/B/F Severe hypertension and
proteinuria with pregnan-
cy (twice)
None ESRD, successful renal
transplantation; recurrent
disease in transplant
12 years
(5 yrs following trans-
plantation)
3 47/W/M Accelerated hypertension,
epistaxis
None ESRD requiring dialysis 1.5 years
4 57/H/F Nephrotic syndrome Steroid—dependent chronic
obstructive lung disease;
hypertension
Mild decline in renal func-
tion. Persistent protein-
uria (nephrotic range).
Continues on steroid
therapy for lung disease
2 years
5 45/W/M Hypertension, Acute renal
insufficiency, Proteinuria
Bells palsy ESRD requiring dialysis 5 years
6 51/W/M Nephrotic syndrome, renal
insufficiency
Hypertension ESRD requiring dialysis 1.5 years
7 80/W/M Acute renal insufficiency Hypertension Initial rapid rise in serum
creatinine, unresponsive
to steroid therapy but im-
provement with plasma-
phoresis; now stable cre-
atinine of 3.0, off
therapy
1 year
Table 2. Laboratory data at time of biopsy
24-hr Urinary
Serum protein
creatinine excretion
Case mg/dl g SIEP UIEP BM
I 8.5 9.0 N N N
2 (1973) 2.0 9.5 N N N
(1985) 2.0 17.0 N N N
3 6.3 5.0 N N ND
4 0.8 6.9 N N N
5 7.0 2.0 N N ND
6 2.9 15.0 N N ND
7 4.9 1.0 N N ND
Abbreviations are: SIEP, serum immunoelectrophoresis; UIEP,
urine immunoelectrophoresis; BM, bone marrow examination; N,
normal; NA, not available; ND, not done.
resected kidneys from patients with diseases of nonglomerular
origin. Portions of the specimens were fixed in glutaraldehyde,
paraformaldehyde mixtures, postfixed in osmium tetroxide, and
embedded in epoxy resin. Thin sections were then stained with
uranyl acetate—lead citrate and examined with a transmission
electron microscope. Fibril thickness was measured at magni-
fications of 30,000 x to 50,000 x and actual width determined
by comparison with similarly magnified photographs of a
germanium—shadowed carbon replica made from a 28,800 line
per inch diffraction grating.
Results
Clinical data
The patients ranged in age from 19 to 80 years at the time of
presentation. Clinical features at presentation, initial laboratory
data, and important follow—up observations are shown in Ta-
bles I and 2.
A broad spectrum of clinical features was encountered. Most,
but not all, patients presented with some degree of renal
insufficiency and most patients had clinical evidence of glomer-
ular involvement. Two patients presented with nephrotic syn-
drome. Most patients had hypertension at the time of presen-
tation. No patient had clinical or laboratory evidence of an
associated lymphoproliferative disorder, dysproteinemia, colla-
gen—vascular disease, immunologic disorder, cryoglobulinemia,
diabetes mellitus, or other systemic disease. Laboratory param-
eters examined in most patients included anti-nuclear antibody,
rheumatoid factor, serum complement, and serum and urine
(concentrated) protein immunoelectrophoresis. Several pa-
tients had bone marrow and/or rectal and liver biopsies per-
formed as part of their evaluation; no significant hematologic or
pathologic abnormalities were discovered by these investiga-
tions. Properly prepared bone marrow tissue for either im-
munofluorescence or cell culture studies was not available for
any of these patients.
Follow—up ranged from one to 12 years. Six of these patients
progressed to end—stage renal disease, usually within one to two
years of diagnosis. One of these patients has received a renal
transplant; the patient remained well with a functioning al-
lograft until she developed evidence of recurrent disease 5.5
years after transplantation and 12 years after initial diagnosis.
All patients remain alive, five requiring dialysis. Several pa-
tients were treated with steroids (Table 1); no patient received
cytotoxic drugs as part of the therapy.
Pathologic data
Light microscopy. Light microscopic features were generally
those of a mild mesangiocapillary glomerulonephritis (Figs. I
and 2 [5]). Non-sclerosed glomerular tufts were usually en-
larged with an accentuated lobular architecture and diffuse,
sometimes segmental expansion of mesangial areas associated
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Fig. 1. Light micrograph of a representative glomerulus from CaseS.
There was an increase in mesangial matrix material, diffusely thickened
capillary walls, and segmental endocapillary cellular proliferation (ar-
rows). Hematoxylin and eosin. 305x.
with deposition of amorphous amphophilic, periodic—acid—
Schiff (PAS) positive material. Glomerular capillary walls
showed variable thickening and infiltration by this amorphous
material, and PAS stains often revealed foci of basement
membrane splitting. Segmental endocapillary cell proliferation
of a variable but usually mild degree was seen in most cases,
and in several biopsies small segmental foci of glomerular
necrosis were observed. In one case, this was accompanied by
small, segmental fibrocellular crescents and adhesions to
Bowman's capsule. In most cases, several glomeruli showed
focal basement—membrane wrinkling, interpreted as ischemic in
origin, associated with arterial and arteriolar sclerosis. Globally
sclerosed glomeruli were present in most biopsies.
Interstitial tissue usually showed prominent tubular atrophy
and interstitial fibrosis, with mononuclear inflammatory cell
infiltrates present in areas of tubular atrophy. Deposits of the
amorphous material were not present in arterial vessels, inter-
stitium, or tubular basement membranes. Congo Red staining
for amyloid was consistently negative throughout the renal
tissue.
Electron microscopy. Ultrastructural examination of non-
selerosed glomeruli showed variable expansion of mesangial
areas with proliferation of mesangial cells. Mesangial expansion
was mostly due to deposition of randomly arranged fibrillar
material similar in appearance to amyloid but seemingly thicker
Fig. 2. PAS stain of a representative glomerulus from Case 5. Capil-
lary wall thickening with prominent splitting of basement membrane
(arrows) is present. 370x.
than usual amyloid fibrils (Fig. 3). This fibrillar material exten-
sively infiltrated capillary basement membranes, involving the
lamina densa and subepithelial layers most often (Fig. 4). Less
extensive deposits of finely granular, non-fibrillar electron—
dense material were seen in association with the fibrillar depos-
its in three cases, with occasional foci where the two types of
deposits appeared to blend into one another. In other cases, the
fibrillar material appeared to be surrounded by electron lucent
areas both in the mesangium and capillary loops. Capillary
basement membranes often showed splitting, with interposition
of either deposits or mesangial cell processes. There was
moderate endothelial cell proliferation and hypertrophy in most
cases. Tubuloreticular inclusions in these cells were absent.
Visceral epithelial cells often were hypertrophied, with diffuse
obliteration of foot processes. No fibrillar or granular deposits
were observed in tubules, interstitium or blood vessels except
in case 2 which showed occasional fibrillar deposits in tubular
basement membranes in the initial biopsy but not in the
transplant.
Measurements of fibril diameters showed thickness of 10 to
12 nm (2 cases), 12 to 15 nm (2 cases) and 15 to 20 rim (3 cases).
(Table 3).
Immunofluorescence microscopy. Six cases showed strong,
coarsely granular or band—like staining of glomeruli in mesan-
gial areas and capillary walls for IgG and kappa light chain (Fig.
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Fig. 3. Case 5, electron micrograph of a glo,nerular capillary loop showing characteristic infiltration offibrillar material in mesangium (M) and
capillary wall (C). Overlying epithelial foot processes are generally effaced (arrows). L, capillary lumen. R, red blood cells. 6850x.
5). Very weak glomerular staining for lambda chain was also
present in three of these cases. One case (case 1) showed
equally strong glomerular staining for kappa and lambda chains,
but no significant staining for heavy chain immunoglobulin
components. All cases showed moderate to strong staining for
C3 in roughly the same distribution as the lgG and kappa chain.
One case showed weak mesangial staining for 1gM, and the
cases with segmental glomerular necrosis showed focal staining
for fibrinogen. Staining for IgA and albumin was negative.
There was no significant staining of the interstitium or tubules.
Arteries showed occasional staining of vessel walls for 1gM and
C3.
Transplant biopsy (Case 2). The morphological and im-
munofluorescence findings of the lesion identified in the trans-
planted kidney were similar to the changes seen in the native
kidneys (Fig. 6). Of note is that an earlier biopsy of the renal
allograft taken three months after transplantation showed no
evidence of recurrent disease; the abnormalities seen at that
time were all attributable to rejection and responded to in-
creased immunosuppressive therapy.
Discussion
Although the presence of extracellular fibrillar material has
been observed in a wide variety of glomerulopathies, most often
this material has represented collagen, fibrin, or normally
occurring components of glomerular basement membrane or
mesangial matrix [14—16]. The size and random arrangement of
the fibrillar material seen in this series of biopsies distinguishes
it from these other components. The differential diagnosis of
lesions composed of randomly arranged, non-tubular, large
fibrillar structures, as observed in our patients, is restricted to
amyloid and amyloid—like lesions that are most often associated
with dysproteinemias or cryoglobulinemia [16]. A limited num-
ber of cases of amyloid—like fibrillar depositions in patients
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Fig. 4. High—power electron micro graph of glomerular capillary wall
from Case 5 showing infiltrating fibrillary material measuring 13—15 nm
in diameter, but which otherwise is indistinguishable in appearance
from amyloid. Adjacent areas of lucency as seen here were common in
this series. 22,800x.
without clinical or laboratory evidence of dysproteinemia have
also been described [7—12, 16].
The lesion observed in this series of patients may be distin-
guished from amyloid by several clinical and morphological
criteria. Clinically, primary amyloidosis is most often a sys-
temic disease; lesions confined to specific visceral organs are
uncommon except when associated with the aging process or
endocrine abnormalities. The biopsy findings in each of our
cases prompted extensive medical evaluation to search for an
underlying systemic disease or multi-organ involvement. In
each case the patient's disease appeared confined to the kid-
neys. In those patients who had biopsies obtained from extra-
renal sites, no deposits of amyloid—like material were seen by
light microscopy, although these extrarenal tissues were not
examined by electron microscopy. After follow—up ranging up
to 12 years, there was no evidence of subsequent development
of systemic amyloidosis or of other diseases associated with
amyloid deposition in any of these patients.
At the present time, the pathologic distinction between
Fig. 5. Case 5. A. Typical immunofluorescence findings show promi-
nent staining of glomerular capillary walls for lgG and B kappa light
chain. Some mesangial staining is also present. Very weak staining for
lambda chain was present in this case.
Table 3. Salient pathologic findings
Immunofluorescence
Case
(glomeruli) .Fibril size
nmIgG K X C3
1 trace 3+ 3+ 2+ 10—12
2 (native kidney) 4+ 4+ 0 2+ 14—15
(renal allograft) 4+ 4+ 0 1+ 14—15
3 3+ 3+ 0 2+ 10—12
4 4+ 4+ 1+ 1+ 17—19
5 4+ 4+ 1+ 2+ 13—15
6 3+ 3+ 1+ 3+ 18—19.5
7 2+ 2+ 0 3+ 18—19
fibrillary glomerulonephritis and amyloidosis rests on fibril size,
histochemical and immunofluorescence features, and patterns
of fibril deposition. Amyloid fibrils have an ultrastructural
appearance that may be characterized as randomly oriented,
•
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Fig. 6. Case 2, A. Electron micrograph of patient's native kidney showing diffuse infiltration by fibrillar material similar to that shown at higher
magnification in Figure 4. 5000x.
straight, and non-branching, and may have features of periodic
beading and/or a tubular appearance on cross section. Chemical
and structural studies providing a high degree of spatial resolu-
tion have shown that these fibrils have a characteristic 13-
pleated structure which in turn is responsible for the character-
istic green birefringence produced when Congo—red—stained
tissue sections are examined under polarized light [16, 17]. The
reported range of the size of amyloid fibrils varies, and figures
of 8 to 10 nm and up to 15 nm have been published by some
investigators [10, 16—21]. However, most authors accept 10 nm
as the upper size limit for usual cases of amyloid [11, 18, 19, 21].
The thickness of the fibrillar deposits seen in this study dem-
onstrates some overlap with the higher limits for amyloid fibrils
used by some investigators, but the range of fibril thickness
encountered in these patients generally was greater than that
usually reported by others and also seen by us in cases of
primary and secondary amyloidosis. Other ultrastructural fea-
tures of the fibrils seen in each of our cases are otherwise
entirely compatible with the appearance of amyloid.
Histochemical and immunofluorescence distinctions between
the present cases and light chain (AL) amyloidosis were multi-
pie. By light microscopy, the absence of tissue staining with the
Congo red reagent in cases of fibrillary glomerulonephritis
provides the sharpest distinction from renal amyloidosis, where
positive birefringence with Congo red staining is invariably
present [17, 21]. The deposited material in the biopsies of the
present series stained positively with the periodic—acid—Schiff
(PAS) reagent, in contrast to the absent staining typical of
amyloid. By immunofluorescence microscopy, the association
of K light chain and IgG was most characteristic. Cases of AL
amyloidosis show staining for either K or more often A light
chains; heavy chain reactivity is usually inconspicuous. How-
ever, caution must be exercised in the interpretation of these
patterns in view of the tendency for amyloid to entrap immu-
noglobulin and light chain components, which result in non-
specific staining by direct immunofluorescence microscopy
[21—24]. All cases in this series stained for kappa chain; only
one of these also showed significant staining for lambda chain as
well. These findings suggest that the physicochemical proper-
ties of either some kappa chains alone or some IgG kappa
immunoglobulins may be important for the formation and
deposition of fibrillar structures seen on electron microscopy.
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Fig. 6 B. Electron micrograph of renal allograft obtained 5.5 years post transplantation showing massive recurrent deposits of librillar material in
mesangium and capillary walls. 5000x.
The patterns of fibril deposition also appeared to differ from
usual patterns of amyloidosis. Glomerular amyloid most often
has the appearance of nodular mesangial deposits, often begin-
ning as a limited segmental process and later becoming more
globally deposited in mesangium and capillary walls [21]. By
contrast, all cases of fibrillary glomerulonephritis showed dif-
fuse and global involvement of glomeruli at the time of first
biopsy with extensive involvement of the mesangium and
peripheral capillary walls. Amyloid is also likely to be deposited
in renal interstitium and blood vessels at the time of glomerular
involvement, while extra—glomerular fibrillary deposits were
seen to a very limited extent in only one of our cases.
Non-amyloidotic fibrillary deposits in glomerulonephritis
have recently been studied by other investigators [10, 12, 251.
Morphologically, some of the cases reported by Duffy et al and
Sturgill, Bolton and Griffith had light microscopic features
similar to ours [10, 12]. However, the immunofluorescence
findings differed; no evidence to suggest principally kappa chain
or IgG kappa chain involvement was noted. Furthermore, by
electron microscopy the fibrils had a distinct tubular structure
and their thickness averaged 20 nm. Korbet et al [251 recently
reported a series of 11 patients with so—called immunotactoid
glomerulopathy. The fibrillar deposits in these patients ap-
peared to differ more clearly from those seen in our series; the
fibrils were larger (approximate range 22 to 49 nm in diameter),
had a definite microtubular appearance and exhibited an orga-
nized pattern of deposition in parallel arrays (their figures 10,
12, 13). However, it is noteworthy that three of the six cases of
immunotactoid glomerulopathy that had immunofluorescence
studies for kappa and lambda chain deposition showed staining
for kappa chains only in the areas of fibrillar deposits. Although
these groups of patients appear to comprise distinct morpho-
logic entities, the small numbers of patients studied thus far
may not be sufficiently large to demonstrate some potential
heterogeneity of the disease process.
The possible relationship between renal amyloidosis, light
chain or monoclonal immunoglobulin nephropathy, and renal
manifestations of lymphoplasmacytic disorders has lately re-
ceived considerable attention [20, 26, 271. In part, this has
resulted from the recognition that light chain deposition disease
and the nephropathy associated with monoclonal gammop-
athies may have an appearance by light microscopy that is
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indistinguishable from renal amyloidosis, that light chain
nephropathy and amyloid may be alternate renal consequences
of lymphoplasmacytic disorders, and that light chains play a
crucia1 role in the pathogenesis of either of these manifesta-
tions. While some investigators have relied on the presence of
fibrillar versus granular deposits on electron microscopy as a
strict discriminant for separating amyloid from light chain or
monoclonal—immunoglobulin deposition diseases [27, 28], this
series suggests that there is a spectrum of ultrastructural
appearances associated with IgG-kappa and kappa chain depo-
sition that ranges from the more widely—recognized granular
dense deposits to fibrillary deposits [12, 26]. It is unknown why
some deposits of light chains may assume an organized struc-
ture characteristic of amyloid while others retain an amor-
phous, granular appearance on electron microscopy. In patients
with amyloidosis of light chain type, the frequency of A chains
as the pathogenic component is significantly greater than i
chains, and this has been ascribed to physicochemical features
of some A chains such as increased susceptibility to in situ
processing or proteolysis [17, 19, 20, 291. This or other physi-
cochemical features of the immunoglobulin or its degradation
products may explain a variable tendency to form fibrils in
patients with IgG-kappa or K light—chain deposition. The under-
lying mechanism for the potentially—nephritogenic light chain or
immunoglobulin secretion in these patients as well as many
patients with primary amyloidosis or systemic K light—chain
deposition disease, given the absence of any underlying
lymphoplasmacytic disorder or demonstrable excess of serum
immunoglobulin components, remains obscure. Leading con-
siderations, which remain largely unproven in most reported
patients, include the production of structurally abnormal immu-
noglobulins and abnormalities of renal parenchyma that result
in entrapment or even a specific binding of immunoglobulin
fragments of specific type [2, 26, 30, 31].
Despite the heterogeneous clinical presentation seen in our
series of patients, a disturbing finding was the propensity of
these patients to progress rapidly to irreversible renal failure.
The series of patients reported by Korbet et al that shares some
of the features seen in our patients also showed a strong
tendency to progress to end—stage renal disease [25]. Although
our experience is too limited to assess whether any cur-
rently—available therapeutic regimens might retard or prevent
this progression, we believe it is important to note that one
patient in this series maintained excellent function in a renal
allograft with no clinical evidence of recurrent disease until 5.5
years after transplantation, when significant proteinul-ia devel-
oped and the characteristic structural features of this disease
were demonstrated in a biopsy of the transplanted kidney.
In summary, we present a series of seven patients with a
perplexing picture of non-amyloidotic fibrillary glomerulone-
phritis with strong tendency to progression to renal failure.
Although a precise etiology for this process remains undeter-
mined, the apparent association with monoclonal lgG kappa
and/or kappa light chain deposition observed in this series is
intriguing and deserves further study. The present cases suggest
the possibility of a physicochemical abnormality of kappa
chains or IgG kappa immunoglobulins that result in either
increased susceptibility to fibril formation or enhanced interac-
tion with certain glomerular matrix components that result in
fibrillar organization and deposition. Elution studies performed
on kidney tissue obtained from these patients should yield
valuable information on the characteristics of the proteins that
are relevant in the pathogenesis of this form of renal injury.
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